Article
Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2015
Shen Yizhen, Bu Meimei, Zhang Aimin, Liu Yi, Fu Baochen
Abstract excerpt
Bladder cancer is the ninth most frequent malignancy in China. Toll-like receptor 4 (TLR4) is expressed on various cells and greatly involves in immune responses. Genetic polymorphism may affect the pathogenesis of diseases through various pathways. In the current study, we evaluated the association between genetic polymorphisms in TLR4 and risk of bladder cancer. We also examined the effect of the polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
